Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis

Kouichi Asano, Motohiro Esaki, Junji Umeno, Atsushi Hirano, Yuji Maehata, Tomohiko Moriyama, Shotaro Nakamura, Takayuki Matsumoto, Takanari Kitazono

研究成果: ジャーナルへの寄稿記事

3 引用 (Scopus)

抄録

Background: Recent genome-wide association studies have identified nearly 100 susceptibility genes for ulcerative colitis (UC). However, the contribution of susceptibility variants for UC to clinical outcome has scarcely been reported. The aim of this study was to investigate whether UC-associated genetic variants confer a risk of clinical relapse. Methods: One hundred and nine consecutive Japanese subjects with quiescent UC were recruited. Four genetic variants of HLA-DRB1*1502, rs6671847 at FCGR2A, rs17085007 at 13q12, and rs2108225 at SLC26A3 were genotyped by Invader assay. The clinical courses were followed after blood sampling, and the risk of relapse according to these genotypes was calculated by Cox proportional hazard model. Results: During the mean follow-up period of 35 months (range 1–81 months), 49 of 109 subjects (45 %) relapsed. Carriers of the G allele of rs6671847 showed an increased risk of relapse compared with non-carriers [adjusted hazard ratio (HR), 2.27; 95 % confidence interval (CI), 1.20–4.32; p = 0.01]. Patients with the CT or TT genotypes of rs17085007 also had an increased risk of relapse compared to subjects with the CC genotype (for CT: adjusted HR, 2.16; 95 % CI, 1.10–4.23; p = 0.03; for TT: adjusted HR, 3.25; 95 % CI, 1.18–8.95; p = 0.02). These two risk variants multiplied the risk of relapse by 2.74 times (95 % CI, 1.10–4.23; p = 0.01) in patients with one risk genotype and 5.40 times (95 % CI, 2.06–14.13; p = 0.0006) in patients with both risk genotypes. Conclusions: Genetic variants of rs6671847 at FCGR2A and rs17085007 at 13q12 conferred a risk of relapse in patients with UC.

元の言語英語
ページ(範囲)1094-1102
ページ数9
ジャーナルJournal of gastroenterology
50
発行部数11
DOI
出版物ステータス出版済み - 3 19 2015

Fingerprint

Ulcerative Colitis
Recurrence
Genotype
Confidence Intervals
HLA-DRB1 Chains
Genome-Wide Association Study
Proportional Hazards Models
Alleles
Genes

All Science Journal Classification (ASJC) codes

  • Gastroenterology

これを引用

Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis. / Asano, Kouichi; Esaki, Motohiro; Umeno, Junji; Hirano, Atsushi; Maehata, Yuji; Moriyama, Tomohiko; Nakamura, Shotaro; Matsumoto, Takayuki; Kitazono, Takanari.

:: Journal of gastroenterology, 巻 50, 番号 11, 19.03.2015, p. 1094-1102.

研究成果: ジャーナルへの寄稿記事

Asano, Kouichi ; Esaki, Motohiro ; Umeno, Junji ; Hirano, Atsushi ; Maehata, Yuji ; Moriyama, Tomohiko ; Nakamura, Shotaro ; Matsumoto, Takayuki ; Kitazono, Takanari. / Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis. :: Journal of gastroenterology. 2015 ; 巻 50, 番号 11. pp. 1094-1102.
@article{e8ff63d4bc0b48ee9d4c5858421e8d48,
title = "Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis",
abstract = "Background: Recent genome-wide association studies have identified nearly 100 susceptibility genes for ulcerative colitis (UC). However, the contribution of susceptibility variants for UC to clinical outcome has scarcely been reported. The aim of this study was to investigate whether UC-associated genetic variants confer a risk of clinical relapse. Methods: One hundred and nine consecutive Japanese subjects with quiescent UC were recruited. Four genetic variants of HLA-DRB1*1502, rs6671847 at FCGR2A, rs17085007 at 13q12, and rs2108225 at SLC26A3 were genotyped by Invader assay. The clinical courses were followed after blood sampling, and the risk of relapse according to these genotypes was calculated by Cox proportional hazard model. Results: During the mean follow-up period of 35 months (range 1–81 months), 49 of 109 subjects (45 {\%}) relapsed. Carriers of the G allele of rs6671847 showed an increased risk of relapse compared with non-carriers [adjusted hazard ratio (HR), 2.27; 95 {\%} confidence interval (CI), 1.20–4.32; p = 0.01]. Patients with the CT or TT genotypes of rs17085007 also had an increased risk of relapse compared to subjects with the CC genotype (for CT: adjusted HR, 2.16; 95 {\%} CI, 1.10–4.23; p = 0.03; for TT: adjusted HR, 3.25; 95 {\%} CI, 1.18–8.95; p = 0.02). These two risk variants multiplied the risk of relapse by 2.74 times (95 {\%} CI, 1.10–4.23; p = 0.01) in patients with one risk genotype and 5.40 times (95 {\%} CI, 2.06–14.13; p = 0.0006) in patients with both risk genotypes. Conclusions: Genetic variants of rs6671847 at FCGR2A and rs17085007 at 13q12 conferred a risk of relapse in patients with UC.",
author = "Kouichi Asano and Motohiro Esaki and Junji Umeno and Atsushi Hirano and Yuji Maehata and Tomohiko Moriyama and Shotaro Nakamura and Takayuki Matsumoto and Takanari Kitazono",
year = "2015",
month = "3",
day = "19",
doi = "10.1007/s00535-015-1062-3",
language = "English",
volume = "50",
pages = "1094--1102",
journal = "Journal of Gastroenterology",
issn = "0944-1174",
publisher = "Springer Japan",
number = "11",

}

TY - JOUR

T1 - Contribution of susceptibility variants at FCGR2A and 13q12 to the risk of relapse among Japanese patients with ulcerative colitis

AU - Asano, Kouichi

AU - Esaki, Motohiro

AU - Umeno, Junji

AU - Hirano, Atsushi

AU - Maehata, Yuji

AU - Moriyama, Tomohiko

AU - Nakamura, Shotaro

AU - Matsumoto, Takayuki

AU - Kitazono, Takanari

PY - 2015/3/19

Y1 - 2015/3/19

N2 - Background: Recent genome-wide association studies have identified nearly 100 susceptibility genes for ulcerative colitis (UC). However, the contribution of susceptibility variants for UC to clinical outcome has scarcely been reported. The aim of this study was to investigate whether UC-associated genetic variants confer a risk of clinical relapse. Methods: One hundred and nine consecutive Japanese subjects with quiescent UC were recruited. Four genetic variants of HLA-DRB1*1502, rs6671847 at FCGR2A, rs17085007 at 13q12, and rs2108225 at SLC26A3 were genotyped by Invader assay. The clinical courses were followed after blood sampling, and the risk of relapse according to these genotypes was calculated by Cox proportional hazard model. Results: During the mean follow-up period of 35 months (range 1–81 months), 49 of 109 subjects (45 %) relapsed. Carriers of the G allele of rs6671847 showed an increased risk of relapse compared with non-carriers [adjusted hazard ratio (HR), 2.27; 95 % confidence interval (CI), 1.20–4.32; p = 0.01]. Patients with the CT or TT genotypes of rs17085007 also had an increased risk of relapse compared to subjects with the CC genotype (for CT: adjusted HR, 2.16; 95 % CI, 1.10–4.23; p = 0.03; for TT: adjusted HR, 3.25; 95 % CI, 1.18–8.95; p = 0.02). These two risk variants multiplied the risk of relapse by 2.74 times (95 % CI, 1.10–4.23; p = 0.01) in patients with one risk genotype and 5.40 times (95 % CI, 2.06–14.13; p = 0.0006) in patients with both risk genotypes. Conclusions: Genetic variants of rs6671847 at FCGR2A and rs17085007 at 13q12 conferred a risk of relapse in patients with UC.

AB - Background: Recent genome-wide association studies have identified nearly 100 susceptibility genes for ulcerative colitis (UC). However, the contribution of susceptibility variants for UC to clinical outcome has scarcely been reported. The aim of this study was to investigate whether UC-associated genetic variants confer a risk of clinical relapse. Methods: One hundred and nine consecutive Japanese subjects with quiescent UC were recruited. Four genetic variants of HLA-DRB1*1502, rs6671847 at FCGR2A, rs17085007 at 13q12, and rs2108225 at SLC26A3 were genotyped by Invader assay. The clinical courses were followed after blood sampling, and the risk of relapse according to these genotypes was calculated by Cox proportional hazard model. Results: During the mean follow-up period of 35 months (range 1–81 months), 49 of 109 subjects (45 %) relapsed. Carriers of the G allele of rs6671847 showed an increased risk of relapse compared with non-carriers [adjusted hazard ratio (HR), 2.27; 95 % confidence interval (CI), 1.20–4.32; p = 0.01]. Patients with the CT or TT genotypes of rs17085007 also had an increased risk of relapse compared to subjects with the CC genotype (for CT: adjusted HR, 2.16; 95 % CI, 1.10–4.23; p = 0.03; for TT: adjusted HR, 3.25; 95 % CI, 1.18–8.95; p = 0.02). These two risk variants multiplied the risk of relapse by 2.74 times (95 % CI, 1.10–4.23; p = 0.01) in patients with one risk genotype and 5.40 times (95 % CI, 2.06–14.13; p = 0.0006) in patients with both risk genotypes. Conclusions: Genetic variants of rs6671847 at FCGR2A and rs17085007 at 13q12 conferred a risk of relapse in patients with UC.

UR - http://www.scopus.com/inward/record.url?scp=84946488868&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946488868&partnerID=8YFLogxK

U2 - 10.1007/s00535-015-1062-3

DO - 10.1007/s00535-015-1062-3

M3 - Article

C2 - 25787843

AN - SCOPUS:84946488868

VL - 50

SP - 1094

EP - 1102

JO - Journal of Gastroenterology

JF - Journal of Gastroenterology

SN - 0944-1174

IS - 11

ER -